Determination of the relative bone mineral-binding affinities of bisphosphonates by using hydroxyapatite-column chromatography combined with mass spectrometric analysis

Determination of the relative bone mineral-binding affinities of bisphosphonates by using hydroxyapatite-column chromatography combined with mass spectrometric analysis

Bibliographic Details
Main Authors:	Duan, X, Xia, Z, Zhang, H, Quijano, M, Dobson, R, Barnett, B, Triffitt, J, Dunford, J, Ebetino, F, Russell, R
Format:	Conference item
Published:	2010

Similar Items

Evaluation of the relative mineral-binding affinities of clinically-relevant bisphosphonates by using hydroxyapatite-column chromatography and adsorption isotherms combined with mass spectrometric analysis
by: Xia, Z, et al.
Published: (2008)

Evaluation of the relative mineral-binding affinities of clinically-relevant bisphosphonates by hydroxyapatite-column chromatography
by: Xia, Z, et al.
Published: (2008)

Refining the use of hydroxyapatite column chromatography to reveal differences in relative binding affinities of bisphosphonates
by: Lawson, M, et al.
Published: (2006)

Potential bone mineral binding differences among bisphosphonates can be demonstrated by the use of hydroxyapatite column chromatography.
by: Lawson, M, et al.
Published: (2005)

Differences between bisphosphonates in binding affinities for hydroxyapatite.
by: Lawson, M, et al.
Published: (2010)

A novel method to characterize relative mineral binding affinities of bisphosphonates and the structural requirements for binding by using ceramic hydroxyapatite column chromatography.
by: Xia, Z, et al.
Published: (2006)

The use of hydroxyapatite column chromatography as a novel method to reveal differences in relative binding affinities of bisphosphonates
by: Lawson, M, et al.
Published: (2005)

Predicting the clinical potencies of bisphosphonates: Divergence of hydroxyapatite and farnesyl diphosphate synthase binding affinities
by: Xia, Z, et al.
Published: (2007)

Differences in the potential binding of phosphate containing compounds to bone mineral are revealed by the novel use of hydroxyapatite column chromatography
by: Lawson, M, et al.
Published: (2005)

Nitrogen-containing bisphosphonates and prediction of their clinical potencies: Dissociation of target enzyme- and hydroxyapatite-binding affinities
by: Xia, Z, et al.
Published: (2007)

Analysis of mineral binding activities of bisphosphonates by using hydroxyapatite chromatography and adsorption isotherms together with detection by light absorption, fluorescence derivatisation and tandem mass spectrometry
by: Xia, Z, et al.
Published: (2008)

Bisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency, together, drive in vivo efficacy
by: Lundy, M, et al.
Published: (2007)

Mineral binding affinities of bisphosphonates.
by: Nancollas, G, et al.
Published: (2002)

The Successful Design Of A Novel Highly Potent Nitrogen-Containing Bisphosphonate With Lower Bone Affinity.
by: Ebetino, F, et al.
Published: (2013)

A computational model explains bisphosphonate binding affinity differences on hydroxyapatite
by: Ebetino, F, et al.
Published: (2006)

A computational model explains bisphosphonate binding affinity differences on hydroxyapatite
by: Ebetino, F, et al.
Published: (2006)

A computational model delineates differences in hydroxyapatite binding affinities of bisphosphonates in clinical use
by: Ebetino, E, et al.
Published: (2005)

Mineral binding affinities and zeta potentials of bisphosphonates
by: Nancollas, G, et al.
Published: (2002)

Predicting pharmacological potencies of nitrogen-containing bisphosphonates; novel methods dissociate enzyme- and hydroxyapatite-binding affinities
by: Xia, Z, et al.
Published: (2007)

Bone mineral affinity influences the distribution of a bisphosphonate and a lower affinity analogue in vivo
by: Roelofs, A, et al.
Published: (2009)

Comparative mineral binding affinities of selected bisphosphonates
by: Nancollas, G, et al.
Published: (2002)

Refining structure activity relationships among nitrogen containing bisphosphonates: Dissociation of mineral binding affinity and inhibitory potency on farnesyl diphosphate synthase.
by: Xia, Z, et al.
Published: (2006)

Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
by: Nancollas, G, et al.
Published: (2006)

The Ability of Bisphosphonates and Their Analogues to Penetrate the Osteocyte Network is Dependent on Affinity for Bone
by: Roelofs, A, et al.
Published: (2010)

Bisphosphonate binding affinity affects drug distribution in both intracortical and trabecular bone of rabbits.
by: Turek, J, et al.
Published: (2012)

Bisphosphonate bone affinity, differences predicted by in vitro binding to carbonated apatite
by: Henneman, Z, et al.
Published: (2004)

Bisphosphonate bone affinity, differences predicted by in vitro carbonated apatite model.
by: Henneman, Z, et al.
Published: (2003)

The mode of binding of nitrogen containing bisphosphonates in farnesyl pyrophosphate synthase
by: Ebetino, F, et al.
Published: (2007)

A mirror image pair of bisphosphonate analogs further demonstrates the mode of binding of the bisphosphonates in farnesyl pyrophosphate synthase
by: Ebetino, F, et al.
Published: (2008)

Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo.
by: Roelofs, A, et al.
Published: (2012)

BONE AFFINITY DIFFERENCES OF NITROGEN-CONTAINING BISPHOSPHONATES PREDICTED BY IN VITRO BINDING TO CARBONATED APATITE
by: Ebetino, F, et al.
Published: (2004)

Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro.
by: Henneman, Z, et al.
Published: (2008)

Differentiation of bisphosphonates based on their physical chemical properties
by: Phipps, R, et al.
Published: (2006)

The pharmacological profile of a novel highly potent bisphosphonate, OX14 (1-Fluoro-2-(Imidazo-[1,2-α]Pyridin-3-yl)-Ethyl-Bisphosphonate)
by: Lawson, M, et al.
Published: (2017)

The relationship between the chemistry and biological activity of the bisphosphonates.
by: Ebetino, F, et al.
Published: (2011)

Substitutions in the R1 hydroxyl and C1 phosphate positions significantly affect binding of risedronate during hydroxyapatite ceramic chromatography
by: Xia, Z, et al.
Published: (2006)

Engineered collagen-hydroxyapatite scaffolds for bone tissue
by: Liu, C, et al.
Published: (2007)

Molecular modeling of the bisphosphonates (BPs) in farnesyl diphosphate (FPP) synthase. Proposed new mechanism of inhibition by potent nitrogen containing bisphosphonates (NBPs).
by: Ebetino, F, et al.
Published: (2002)

Modeling of bisphosphonate binding to farnesyl diphosphate synthase
by: Ebetino, F, et al.
Published: (2002)

Substitution of the R1 hydroxyl and C1 phosphate of risedronate produces differences in elution profiles on hydroxyapatite ceramic chromatographic columns
by: Xia, Z, et al.
Published: (2006)